JPH0451551B2 - - Google Patents
Info
- Publication number
- JPH0451551B2 JPH0451551B2 JP12068484A JP12068484A JPH0451551B2 JP H0451551 B2 JPH0451551 B2 JP H0451551B2 JP 12068484 A JP12068484 A JP 12068484A JP 12068484 A JP12068484 A JP 12068484A JP H0451551 B2 JPH0451551 B2 JP H0451551B2
- Authority
- JP
- Japan
- Prior art keywords
- reaction
- hydantoin
- yield
- hydroxybenzaldehyde
- mol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- WJRBRSLFGCUECM-UHFFFAOYSA-N hydantoin Chemical compound O=C1CNC(=O)N1 WJRBRSLFGCUECM-UHFFFAOYSA-N 0.000 claims description 12
- 229940091173 hydantoin Drugs 0.000 claims description 11
- 150000001413 amino acids Chemical class 0.000 claims description 4
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 claims description 4
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims 1
- RGHHSNMVTDWUBI-UHFFFAOYSA-N 4-hydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1 RGHHSNMVTDWUBI-UHFFFAOYSA-N 0.000 description 13
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 10
- 239000004471 Glycine Substances 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- SATCULPHIDQDRE-UHFFFAOYSA-N piperonal Chemical compound O=CC1=CC=C2OCOC2=C1 SATCULPHIDQDRE-UHFFFAOYSA-N 0.000 description 4
- 125000001424 substituent group Chemical group 0.000 description 4
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- IBGBGRVKPALMCQ-UHFFFAOYSA-N 3,4-dihydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1O IBGBGRVKPALMCQ-UHFFFAOYSA-N 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- -1 aryl aldehyde Chemical class 0.000 description 2
- 229940000635 beta-alanine Drugs 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- WTWBUQJHJGUZCY-UHFFFAOYSA-N cuminaldehyde Chemical compound CC(C)C1=CC=C(C=O)C=C1 WTWBUQJHJGUZCY-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 2
- 150000001469 hydantoins Chemical class 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- ZRSNZINYAWTAHE-UHFFFAOYSA-N p-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1 ZRSNZINYAWTAHE-UHFFFAOYSA-N 0.000 description 2
- FXLOVSHXALFLKQ-UHFFFAOYSA-N p-tolualdehyde Chemical compound CC1=CC=C(C=O)C=C1 FXLOVSHXALFLKQ-UHFFFAOYSA-N 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- SMQUZDBALVYZAC-UHFFFAOYSA-N salicylaldehyde Chemical compound OC1=CC=CC=C1C=O SMQUZDBALVYZAC-UHFFFAOYSA-N 0.000 description 2
- 235000011121 sodium hydroxide Nutrition 0.000 description 2
- 229960003080 taurine Drugs 0.000 description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- GSTYGEGWJKJKQF-XVNBXDOJSA-N (5e)-5-(1,3-benzodioxol-5-ylmethylidene)imidazolidine-2,4-dione Chemical compound N1C(=O)NC(=O)\C1=C/C1=CC=C(OCO2)C2=C1 GSTYGEGWJKJKQF-XVNBXDOJSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- PCYGLFXKCBFGPC-UHFFFAOYSA-N 3,4-Dihydroxy hydroxymethyl benzene Natural products OCC1=CC=C(O)C(O)=C1 PCYGLFXKCBFGPC-UHFFFAOYSA-N 0.000 description 1
- CKTUXQBZPWBFDX-UHFFFAOYSA-N 3-azaniumylcyclohexane-1-carboxylate Chemical compound NC1CCCC(C(O)=O)C1 CKTUXQBZPWBFDX-UHFFFAOYSA-N 0.000 description 1
- SKLUWKYNZNXSLX-UHFFFAOYSA-N 4-Acetamidobenzaldehyde Chemical compound CC(=O)NC1=CC=C(C=O)C=C1 SKLUWKYNZNXSLX-UHFFFAOYSA-N 0.000 description 1
- SEVSMVUOKAMPDO-UHFFFAOYSA-N 4-acetoxy benzaldehyde Chemical compound CC(=O)OC1=CC=C(C=O)C=C1 SEVSMVUOKAMPDO-UHFFFAOYSA-N 0.000 description 1
- AVPYQKSLYISFPO-UHFFFAOYSA-N 4-chlorobenzaldehyde Chemical compound ClC1=CC=C(C=O)C=C1 AVPYQKSLYISFPO-UHFFFAOYSA-N 0.000 description 1
- UOQXIWFBQSVDPP-UHFFFAOYSA-N 4-fluorobenzaldehyde Chemical compound FC1=CC=C(C=O)C=C1 UOQXIWFBQSVDPP-UHFFFAOYSA-N 0.000 description 1
- QRVYABWJVXXOTN-UHFFFAOYSA-N 4-methylsulfanylbenzaldehyde Chemical compound CSC1=CC=C(C=O)C=C1 QRVYABWJVXXOTN-UHFFFAOYSA-N 0.000 description 1
- GXPDYJIBYGLMKU-UHFFFAOYSA-N 5-[(2-hydroxyphenyl)methylidene]imidazolidine-2,4-dione Chemical compound OC1=CC=CC=C1C=C1C(=O)NC(=O)N1 GXPDYJIBYGLMKU-UHFFFAOYSA-N 0.000 description 1
- UPDDIBZITPTASO-UHFFFAOYSA-N 5-[(4-hydroxyphenyl)methylidene]imidazolidine-2,4-dione Chemical compound C1=CC(O)=CC=C1C=C1C(=O)NC(=O)N1 UPDDIBZITPTASO-UHFFFAOYSA-N 0.000 description 1
- MDJFPRDVZHNPSA-UHFFFAOYSA-N 5-[(4-methylphenyl)methylidene]imidazolidine-2,4-dione Chemical compound C1=CC(C)=CC=C1C=C1C(=O)NC(=O)N1 MDJFPRDVZHNPSA-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ZGUNAGUHMKGQNY-ZETCQYMHSA-N L-alpha-phenylglycine zwitterion Chemical compound OC(=O)[C@@H](N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-ZETCQYMHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical group Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- GBFLZEXEOZUWRN-VKHMYHEASA-N S-carboxymethyl-L-cysteine Chemical compound OC(=O)[C@@H](N)CSCC(O)=O GBFLZEXEOZUWRN-VKHMYHEASA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 1
- 125000005236 alkanoylamino group Chemical group 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- 229940040526 anhydrous sodium acetate Drugs 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- HUMNYLRZRPPJDN-KWCOIAHCSA-N benzaldehyde Chemical group O=[11CH]C1=CC=CC=C1 HUMNYLRZRPPJDN-KWCOIAHCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960003646 lysine Drugs 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 210000003739 neck Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- GJBHGUUFMNITCI-QTNFYWBSSA-M sodium;(2s)-2-aminopentanedioate;hydron;hydrate Chemical compound O.[Na+].OC(=O)[C@@H](N)CCC([O-])=O GJBHGUUFMNITCI-QTNFYWBSSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
Description
【発明の詳細な説明】
本発明は、5−アリーリデンヒダントインの製
造方法に関するものである。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing 5-arylidenehydantoin.
5−アリーリデンヒダントインは芳香核に置換
基を有するフエニルアラニンを製造するための重
要な中間体である。 5-arylidenehydantoin is an important intermediate for producing phenylalanine having a substituent on the aromatic nucleus.
アルデヒド類とヒダントイン類を縮合させて5
−置換ヒダントイン類を製造する反応は、
Wheeler−Hoffman反応と呼ばれ、公知である。
(J.Am,Chem,Soc.、45、369(1911))。この方
法では反応は酢酸及び無水酢酸ナトリウムの存在
下で行なわれる。またこの反応についての別の詳
細な例は、Org.Syn.、Coll.Vol.5627に記載され
ており、反応は無水ピペラジン中で行なわれてい
る。これらの方法は、いずれも高価な有機溶媒を
使用しており、また収率も70%程度と低いため
に、工業的に満足すべきものではない。 By condensing aldehydes and hydantoins, 5
-The reaction for producing substituted hydantoins is
It is called the Wheeler-Hoffman reaction and is well known.
(J. Am, Chem, Soc., 45, 369 (1911)). In this method the reaction is carried out in the presence of acetic acid and anhydrous sodium acetate. Another detailed example of this reaction is given in Org. Syn., Coll. Vol. 5627, where the reaction is carried out in anhydrous piperazine. All of these methods use expensive organic solvents and yields are as low as about 70%, so they are not industrially satisfactory.
本発明は、アリールアルデヒドをアミノ酸の存
在下、PH8〜12の範囲でヒダントイン(2,4−
イミダゾリジンジオン)と反応させることによ
り、工業的に有利に5−アリーリデンヒダントイ
ンを製造する方法を提供するものである。本発明
によれば、水系の溶媒中で、比較的短かい反応時
間内に結晶性の良い5−アリーリデンヒダントイ
ンを好収率で得ることができる。 In the present invention, hydantoin (2,4-
The present invention provides an industrially advantageous method for producing 5-arylidenehydantoin by reacting it with 5-arylidenehydantoin (imidazolidinedione). According to the present invention, 5-arylidenehydantoin with good crystallinity can be obtained in a good yield within a relatively short reaction time in an aqueous solvent.
本発明の原料であるアリールアルデヒドとして
は、ハロゲン原子、水酸基、低級アルコキシ基、
低級アルキルメルカプト基、低級アルキル基、低
級アルカノイル基、低級アルカノイルアミノ基、
の少くとも1種にて置換されたベンズアルデヒド
が用いられる。置換基が2以上のとき該置換基は
同一でも異なつても良く、また2つの置換基が互
いに結合して環状となつても良い。これらの代表
的なものを例示すれば、例えば、p−ヒドロキシ
ベンズアルデヒド,3,4−ジオキシベンズアル
デヒド,p−メトキシベンズアルデヒド,p−メ
チルベンズアルデヒド,o−ヒドロキシベンズア
ルデヒド,3,4−メチレンジオキシベンズアル
デヒド,p−エチルベンズアルデヒド,p−イソ
プロピルベンズアルデヒド,p−アセトキシベン
ズアルデヒド,p−アセトアミノベンズアルデヒ
ド,p−メチルチオベンズアルデヒド,p−クロ
ロベンズアルデヒド,p−フロロベンズアルデヒ
ドなどが使用できる。 The aryl aldehyde that is the raw material of the present invention includes a halogen atom, a hydroxyl group, a lower alkoxy group,
lower alkylmercapto group, lower alkyl group, lower alkanoyl group, lower alkanoylamino group,
Benzaldehyde substituted with at least one of the following is used. When there are two or more substituents, the substituents may be the same or different, and the two substituents may be bonded to each other to form a ring. Typical examples of these include p-hydroxybenzaldehyde, 3,4-dioxybenzaldehyde, p-methoxybenzaldehyde, p-methylbenzaldehyde, o-hydroxybenzaldehyde, 3,4-methylenedioxybenzaldehyde, p-Ethylbenzaldehyde, p-isopropylbenzaldehyde, p-acetoxybenzaldehyde, p-acetaminobenzaldehyde, p-methylthiobenzaldehyde, p-chlorobenzaldehyde, p-fluorobenzaldehyde, etc. can be used.
本発明で使用される反応溶媒としては、一般に
水が用いられるが、水のみならず、必要に応じて
メタノール,エタノール,ジオキサンなどの水に
可溶な有機溶媒を水と混合したものを使用するこ
ともできる。 Water is generally used as the reaction solvent in the present invention, but not only water but also a mixture of water and a water-soluble organic solvent such as methanol, ethanol, dioxane, etc. may be used if necessary. You can also do that.
使用するアミノ酸としては、グルタミン酸,ア
スパラギン酸,リジン,アルギニン,オルニチ
ン,グリシン,α−アラニン,ロイシン,イソロ
イシン,バリン,β−アラニン,フエニルアラニ
ン,チロシン,ドーパ,フエニルグリシン,セリ
ン,スレオニン,メチオニン,タウリン,S−カ
ルボキシメチルシステイン,γ−アミノ酪酸,ト
ラネキサム酸,3−アミノシクロヘキサンカルボ
ン酸などを、単独に、又は、混合して使用でき
る。またこれらアミノ酸の塩、例えばアルカリ金
属,アルカリ土類金属塩や鉱酸塩等を用いること
もできる。これらの使用量はヒダントインに対し
て0.1〜2モル比、好ましくは0.3〜1モル比が良
い。少ないと効果が少なく、また多く使用しても
それに見合う効果が得られず、経済的でない。 Amino acids used include glutamic acid, aspartic acid, lysine, arginine, ornithine, glycine, α-alanine, leucine, isoleucine, valine, β-alanine, phenylalanine, tyrosine, dopa, phenylglycine, serine, threonine, methionine. , taurine, S-carboxymethylcysteine, γ-aminobutyric acid, tranexamic acid, 3-aminocyclohexanecarboxylic acid, etc. can be used alone or in combination. Furthermore, salts of these amino acids, such as alkali metal or alkaline earth metal salts or mineral acid salts, can also be used. The amount of these used is preferably 0.1 to 2 molar ratio, preferably 0.3 to 1 molar ratio to hydantoin. If the amount is too small, the effect will be low, and even if it is used in large amount, the corresponding effect will not be obtained, which is not economical.
反応時のPHは8〜12、好ましくは9〜10が良
い。アミノ酸を中性ないし酸性で使用しても効果
は得られず、上記PHに反応液PHを調製する必要が
ある。PHの調製に使用するアルカリの種類として
は、特に制限はなく、例えば、水酸化ナトリウ
ム,水酸化カリウム,炭酸ナトリウム,炭酸カリ
ウムなどのアルカリ金属水酸化物およびそれらの
炭酸塩,水酸化マグネシウム,水酸化カルシウム
等のアルカリ土類金属水酸化物等が使用できる。 The pH during the reaction is preferably 8 to 12, preferably 9 to 10. Even if the amino acid is used in a neutral or acidic state, no effect is obtained, and it is necessary to adjust the pH of the reaction solution to the above-mentioned pH. There are no particular restrictions on the type of alkali used to prepare the PH, and examples include alkali metal hydroxides such as sodium hydroxide, potassium hydroxide, sodium carbonate, and potassium carbonate, and their carbonates, magnesium hydroxide, and water. Alkaline earth metal hydroxides such as calcium oxide can be used.
反応温度及び時間については、必ずしも厳密な
制限はないが、通常は、40〜100℃好ましくは60
〜80℃であり、1〜10時間、好ましくは2〜5時
間である。 The reaction temperature and time are not necessarily strictly limited, but are usually 40 to 100°C, preferably 60°C.
~80°C for 1 to 10 hours, preferably 2 to 5 hours.
反応生成物である5−アリーリデンヒダントイ
ンは水に難溶性であるので、反応の進行と共に結
晶として析出するので遠心分離等の方法により、
容易に分離回収することができる。 Since the reaction product 5-arylidenehydantoin is poorly soluble in water, it precipitates as crystals as the reaction progresses, so it can be removed by methods such as centrifugation.
It can be easily separated and recovered.
以下実施例によつて、本発明の方法について更
に具体的に説明する。但し、これらは説明のため
の単なる例示であり、本発明は、これらの例に何
ら制限されない。 The method of the present invention will be explained in more detail below with reference to Examples. However, these are merely examples for explanation, and the present invention is not limited to these examples in any way.
実施例 1
温度計、還流冷却器、攪拌器を備えた3つ口
500mlセパラブルフラスコを恒温槽中にセツトし
た。Example 1 Three necks equipped with thermometer, reflux condenser and stirrer
A 500ml separable flask was placed in a thermostatic bath.
水200ml,ヒダントイン50.0g(=0.50mol),
グリシン18.8g(=0.25mol),固型カセイソーダ
5.0g(=0.125mol),p−ヒドロキシベンズアル
デヒド61.1g(=0.50mol)を入れて昇温し、80
℃にて2時間攪拌した。この間反応液のPHは9.8
〜9.6であつた。室温まで冷却した後、遠心分離
により、5−p−ヒドロキシベンジリデンヒダン
トイン93.0gを得た。ヒダントインに対し、91.2
%の収率であつた。 200ml of water, 50.0g of hydantoin (=0.50mol),
Glycine 18.8g (=0.25mol), solid caustic soda
Add 5.0 g (=0.125 mol) and 61.1 g (=0.50 mol) of p-hydroxybenzaldehyde and raise the temperature to 80
The mixture was stirred at ℃ for 2 hours. During this time, the pH of the reaction solution was 9.8.
It was ~9.6. After cooling to room temperature, 93.0 g of 5-p-hydroxybenzylidenehydantoin was obtained by centrifugation. 91.2 for hydantoin
% yield.
実施例 2
実施例1において、グリシンをL−リジン・塩
酸塩45.7g(=0.25mol),p−ヒドロキシベンズ
アルデヒドを3,4−ジヒドロキシベンズアルデ
ヒド69.1g(=0.50mol)にかえて、同様に反応,
操作した。この間、反応液のPHは9.4〜9.2であつ
た。5−(3,4−ジヒドロキシベンジリデン)−
ヒダントインの収量102.5g。ヒダトインに対し、
93.2%の収率であつた。Example 2 In Example 1, the reaction was carried out in the same manner as in Example 1, except that glycine was replaced with 45.7 g (=0.25 mol) of L-lysine hydrochloride and p-hydroxybenzaldehyde was replaced with 69.1 g (=0.50 mol) of 3,4-dihydroxybenzaldehyde.
operated. During this time, the pH of the reaction solution was 9.4 to 9.2. 5-(3,4-dihydroxybenzylidene)-
Yield of hydantoin: 102.5g. For hydatoin,
The yield was 93.2%.
実施例 3
実施例1において、グリシンをL−グルタミン
酸ソーダ・一水塩46.8g(=0.25mol)に、p−
ヒドロキシベンズアルデヒドをp−メトキシベン
ズアルデヒド68.1g(=0.50mol)にかえて同様
に反応,操作した。この間、反応液のPHは9.9〜
9.7であつた。5−(p−メトキシベンジリデン)
−ヒダントインの収量104.5g。ヒダントインに
対し95.9%の収率であつた。Example 3 In Example 1, glycine was added to 46.8 g (=0.25 mol) of sodium L-glutamate monohydrate and p-
The same reaction and operation were carried out except that 68.1 g (=0.50 mol) of p-methoxybenzaldehyde was used instead of hydroxybenzaldehyde. During this time, the pH of the reaction solution is 9.9~
It was 9.7. 5-(p-methoxybenzylidene)
-Yield of hydantoin 104.5g. The yield was 95.9% based on hydantoin.
実施例 4
実施例1において、グリシンをタウリン31.3g
(=0.25mol)に、p−ヒドロキシベンズアルデ
ヒドをp−トルアルデヒド60.0g(=0.50mol)
にかえて、同様に反応,操作した。この間、反応
液のPHは9.8〜9.6であつた。5−(p−メチルベ
ンジリデン)−ヒダントインの収量94.5g。ヒダ
ントインに対し、93.6%の収率であつた。Example 4 In Example 1, 31.3g of taurine was substituted for glycine.
(=0.25mol), p-hydroxybenzaldehyde and p-tolualdehyde 60.0g (=0.50mol)
Instead, the reaction and operation were carried out in the same way. During this time, the pH of the reaction solution was 9.8 to 9.6. Yield of 5-(p-methylbenzylidene)-hydantoin: 94.5 g. The yield was 93.6% based on hydantoin.
実施例 5
実施例1において、グリシンをβ−アラニン
22.2g(=0.25mol)に、p−ヒドロキシベンズ
アルデヒドをo−ヒドロキシベンズアルデヒド
61.1g(=0.50mol)にかえて、同様に6時間反
応させた。この間、反応液のPHは、9.6〜9.2であ
つた。5−(o−ヒドロキシベンジリデン)−ヒダ
ントインの収量89.3g。ヒダントインに対して
87.5%の収率であつた。Example 5 In Example 1, glycine was replaced with β-alanine.
22.2g (=0.25mol) of p-hydroxybenzaldehyde was added to o-hydroxybenzaldehyde.
The amount was changed to 61.1 g (=0.50 mol) and the reaction was carried out in the same manner for 6 hours. During this time, the pH of the reaction solution was 9.6 to 9.2. Yield of 5-(o-hydroxybenzylidene)-hydantoin: 89.3 g. against hydantoin
The yield was 87.5%.
実施例 6
実施例1において、p−ヒドロキシベンズアル
デヒドを3,4−メチレンジオキシベンズアルデ
ヒド75.0g(=0.50mol)にかえて、同様に反応,
操作した。この間、反応液のPHは9.8〜9.6であつ
た。5−(3,4−メチレンジオキシベンジリデ
ン)−ヒダントインの収量109.1g。ヒダントイン
に対して94.1%の収率であつた。Example 6 In Example 1, the reaction was carried out in the same manner, except that p-hydroxybenzaldehyde was replaced with 75.0 g (=0.50 mol) of 3,4-methylenedioxybenzaldehyde.
operated. During this time, the pH of the reaction solution was 9.8 to 9.6. Yield of 5-(3,4-methylenedioxybenzylidene)-hydantoin: 109.1 g. The yield was 94.1% based on hydantoin.
Claims (1)
ドを除く)をアミノ酸又はその塩の存在下、PH8
〜12の範囲の水性溶液中でヒダントインと反応さ
せることを特徴とする5−アリーリデンヒダント
イン類の製造方法。1 Arylaldehyde (excluding benzaldehyde) in the presence of an amino acid or its salt at pH 8
1. A method for producing 5-arylidenehydantoins, characterized by reacting them with hydantoin in an aqueous solution in the range of 5-12.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP12068484A JPS611668A (en) | 1984-06-14 | 1984-06-14 | Production of 5-arylidenehydantoin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP12068484A JPS611668A (en) | 1984-06-14 | 1984-06-14 | Production of 5-arylidenehydantoin |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS611668A JPS611668A (en) | 1986-01-07 |
JPH0451551B2 true JPH0451551B2 (en) | 1992-08-19 |
Family
ID=14792388
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP12068484A Granted JPS611668A (en) | 1984-06-14 | 1984-06-14 | Production of 5-arylidenehydantoin |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS611668A (en) |
-
1984
- 1984-06-14 JP JP12068484A patent/JPS611668A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS611668A (en) | 1986-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SU784776A3 (en) | Method of preparing quinazolone derivatives | |
JP3190442B2 (en) | Method for producing α-amino acid, p-hydroxyphenylglycine, amino acid ester and amino acid amide | |
JPH06271524A (en) | Preparation of aromatic nitrile | |
US8183408B2 (en) | Process for production of N-carbamoyl-tert-leucine | |
JPH0451551B2 (en) | ||
KR20060052532A (en) | Hydroxynaphthoic acid hydrazide compound and method for preparing the same | |
KR101755291B1 (en) | Process for the preparation of thyroid hormones and salts thereof | |
US4672127A (en) | Process for production of hydantoin derivatives | |
US4259525A (en) | Methionine process | |
JPH0451552B2 (en) | ||
US3442909A (en) | Alpha-methyl-beta-(3,4-disubstitutedphenyl) propionitriles | |
JPH0524899B2 (en) | ||
Gaudry | Study on the synthesis of valine by the Strecker method | |
JPH0548227B2 (en) | ||
SU453827A3 (en) | METHOD OF OBTAINING p-AMINO-p-PHENYLPROPIONIC ACID | |
US2523744A (en) | Synthesis of aspartic acid | |
US2530570A (en) | Pyrimidylmercapto-carboxylic acids | |
KR100235376B1 (en) | 2-aminonaphthyridine derivative and its preparation | |
KR100235373B1 (en) | Process for the preparation of a dextrogyral isomer of an isoindolinone derivative | |
US4334087A (en) | Process for preparing α-ketocarboxylic acids | |
US3790598A (en) | Process for preparing alpha-amino acids | |
CN109553629A (en) | A kind of preparation method of Cefuroxime Sodium intermediate E type impurity compound | |
JP3082006B2 (en) | Method for producing 2-alkylthio-4,6-dihydroxypyrimidine | |
JPH06279414A (en) | Preparation of aryl hydantoin | |
JPS606638A (en) | Production of alpha-ketoacid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EXPY | Cancellation because of completion of term |